BRISTOL-MYERS SQUIBB COMPANY
Entity uei:UFGKB2B71N12 · UEI UFGKB2B71N12
Obligations by fiscal year
FY2026
$1.5M
Awards (9)
| 36C24526N0776↗ MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST) | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Aug 2, 2026 – Sep 30, 2026 | $300K | — | 0 |
| 36C24526N0288↗ MAVACAMTEN (CAMZYOS) 5 MG AND POMALIDOMIDE (POMALYST) 2 MG | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Feb 17, 2026 – Sep 30, 2026 | $233K | — | 0 |
| 36C24526N0790↗ POMALYST 2 MG, 3 MG,4 MG | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Aug 2, 2026 – Aug 31, 2026 | $199K | — | 0 |
| 36C24526N0616↗ POMALYST 2 MG, 3 MG,4 MG | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | May 29, 2026 – Jun 4, 2026 | $149K | — | 0 |
| 36C24526N0553↗ PATIENT MEDICATION OF POMALYST 2MG, 3MNG, 4MG. TO BE SHIPPED TO THE BALTIMORE VA MEDICAL CENTER. | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Apr 27, 2026 – May 4, 2026 | $139K | — | 0 |
| 36C24526N0474↗ POMALYST 2 MG, 4 MG | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Apr 7, 2026 – Apr 30, 2026 | $139K | — | 0 |
| 36C24526N0715↗ POMALYST 2 MG, 3 MG,4 MG | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Jul 7, 2026 – Jul 24, 2026 | $138K | — | 0 |
| 36C24526N0375↗ POMALYST 2MG, 4MG | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Feb 26, 2026 – Mar 6, 2026 | $127K | — | 0 |
| 36C26026F0154↗ CAMZYOS, POMALYST, AND REVLIMID | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Jan 20, 2026 – Jul 20, 2026 | $110K | — | 0 |
Observed spellings (1)
Raw recipient names from source records that resolved to this entity.
- BRISTOL-MYERS SQUIBB COMPANY
UFGKB2B71N12· seen 27×